Skip to main content

Advertisement

SpringerLink
Log in

Prophylaxis of Pulmonary Embolism in Kidney Transplant Recipients

  • Kidney Diseases (G Ciancio, Section Editor)
  • Published:
Current Urology Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

Kidney transplant recipients have an increased risk of pulmonary embolism; however, thromboprophylaxis poses a challenge as the risk of thrombosis must be balanced against the risk of bleeding. This review summarizes the evidence on whether thromboprophylaxis is required in kidney transplantation.

Recent Findings

Incidence of venous thromboembolism, comprising pulmonary embolism and deep venous thrombosis, is increased in kidney transplant recipients compared to the general population, with augmented risk of death and graft loss. Findings suggest a benefit of prophylaxis with heparin and mechanical prophylaxis for low-risk patients. For patients at high risk, with previous thrombosis, and/or abnormal thrombophilia screen, dose and prophylaxis time need to be increased.

Summary

There is no established thromboprophylaxis strategy. It is crucial to evaluate patient’s risk profile and opt for a multidisciplinary approach for the development of appropriate prophylaxis. There remains a paucity of high-quality evidence for effective prophylaxis strategies in this population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Martinelli I, De Stefano V, Mannucci PM. Inherited risk factors for venous thromboembolism. Nat Rev Cardiol. 2014;11(3):140–56. https://doi.org/10.1038/nrcardio.2013.211.

    Article  CAS  PubMed  Google Scholar 

  2. Tapson VF. Acute pulmonary embolism. N Engl J Med. 2008;358(10):1037–52. https://doi.org/10.1056/NEJMra072753.

    Article  CAS  PubMed  Google Scholar 

  3. Hall D. Perioperative pulmonary embolism: detection, treatment, and outcomes. Am J Ther. 2013;20(1):67–72. https://doi.org/10.1097/MJT.0b013e31824d61a4.

    Article  PubMed  Google Scholar 

  4. Abbott KC, Cruess DF, Agodoa LY, Sawyers ES, Tveit DP. Early renal insufficiency and late venous thromboembolism after renal transplantation in the United States. Am J Kidney Dis. 2004;43(1):120–30. https://doi.org/10.1053/j.ajkd.2003.08.047.

    Article  PubMed  Google Scholar 

  5. • Lam NN, Garg AX, Knoll GA, Kim SJ, Lentine KL, McArthur E, et al. Venous thromboembolism and the risk of death and graft loss in kidney transplant recipients. Am J Nephrol. 2017;46(4):343–54. https://doi.org/10.1159/000480304. Study with current cohort and clinically important outcomes.

    Article  PubMed  Google Scholar 

  6. Zoccali C, Mallamaci F. Pulmonary embolism in chronic kidney disease: a lethal, overlooked and research orphan disease. J Thromb Haemost. 2012;10(12):2481–3. https://doi.org/10.1111/jth.12046.

    Article  CAS  PubMed  Google Scholar 

  7. Pavord S, Myers B. Bleeding and thrombotic complications of kidney disease. Blood Rev. 2011;25(6):271–8. https://doi.org/10.1016/j.blre.2011.07.001.

    Article  PubMed  Google Scholar 

  8. Saez-Gimenez B, Berastegui C, Loor K, Lopez-Meseguer M, Monforte V, Bravo C, et al. Deep vein thrombosis and pulmonary embolism after solid organ transplantation: an unresolved problem. Transplant Rev (Orlando). 2015;29(2):85–92. https://doi.org/10.1016/j.trre.2014.12.005.

    Article  Google Scholar 

  9. Ahn S, Kim MH, Jun KW, Hwang JK, Park SC, Moon IS, et al. The incidence and risk factors for deep vein thrombosis after kidney transplantation in Korea: single-center experience. Clin Transpl. 2015;29(12):1181–6. https://doi.org/10.1111/ctr.12648.

    Article  Google Scholar 

  10. Humar A, Matas AJ. Surgical complications after kidney transplantation. Semin Dial. 2005;18(6):505–10. https://doi.org/10.1111/j.1525-139X.2005.00097.x.

    Article  PubMed  Google Scholar 

  11. Kim MH, Hwang JK, Chun HJ, Moon IS, Kim JI. Thrombosed hemodialysis access as an unusual source of emboli in the upper extremity of a kidney transplant recipient. Hemodial Int. 2014;18(2):535–9. https://doi.org/10.1111/hdi.12118.

    Article  PubMed  Google Scholar 

  12. Kupeli E, Ulubay G, Colak T, Ozdemirel TS, Ozyurek BA, Akcay S, et al. Pulmonary complications in renal recipients after transplantation. Transplant Proc. 2011;43(2):551–3. https://doi.org/10.1016/j.transproceed.2011.01.063.

    Article  CAS  PubMed  Google Scholar 

  13. Kupeli E, Ulubay G, Dogrul I, Birben O, Seyfettin P, Ozsancak Ugurlu A, et al. Long-term risk of pulmonary embolism in solid-organ transplant recipients. Exp Clin Transplant. 2015;13(Suppl 1):223–7.

    PubMed  Google Scholar 

  14. Poli D, Zanazzi M, Antonucci E, Bertoni E, Salvadori M, Abbate R, et al. Renal transplant recipients are at high risk for both symptomatic and asymptomatic deep vein thrombosis. J Thromb Haemost. 2006;4(5):988–92. https://doi.org/10.1111/j.1538-7836.2006.01917.x.

    Article  CAS  PubMed  Google Scholar 

  15. Sakhuja A, Stephany B, Deitzer D, Kumar G, Schold JD. Trends of pulmonary embolism before and after kidney transplantation in black versus white patients. Transplant Proc. 2014;46(5):1353–61. https://doi.org/10.1016/j.transproceed.2014.01.019.

    Article  CAS  PubMed  Google Scholar 

  16. Tveit DP, Hypolite I, Bucci J, Hshieh P, Cruess D, Agodoa LY, Welch PG, Abbott KC. Risk factors for hospitalizations resulting from pulmonary embolism after renal transplantation in the United States. J Nephrol. 2001;14:361–8

    CAS  PubMed  Google Scholar 

  17. Tveit DP, Hypolite IO, Hshieh P, Cruess D, Agodoa LY, Welch PG, et al. Chronic dialysis patients have high risk for pulmonary embolism. Am J Kidney Dis. 2002;39(5):1011–7. https://doi.org/10.1053/ajkd.2002.32774.

    Article  PubMed  Google Scholar 

  18. Kumar G, Sakhuja A, Taneja A, Majumdar T, Patel J, Whittle J, et al. Milwaukee Initiative in Critical Care Outcomes Research Group of Investigators: pulmonary embolism in patients with CKD and ESRD. Clin J Am Soc Nephrol. 2012;7(10):1584–90. https://doi.org/10.2215/CJN.00250112.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Ubhi C, Lam F, Mavor A, Giles G. Subcutaneous heparin therapy for cyclosporine-immunosuppressed renal allograft recipients. Transplantation. 1989;49(5):886.

    Article  Google Scholar 

  20. Alkhunaizi A, Olyaei A, Barry J, de Mattos A, Conlin M, Lemmers M, et al. Efficacy and safety of low molecular weight heparin in renal transplantation. Transplantation. 1998;66(4):533–4. https://doi.org/10.1097/00007890-199808270-00020.

    Article  CAS  PubMed  Google Scholar 

  21. Robertson AJ, Nargund V, Gray DWR, Morris PJ. Low dose aspirin as prophylaxis against renal-vein thrombosis in renal-transplant recipients. Nephrol Dial Transplant. 2000;15(11):1865–8. https://doi.org/10.1093/ndt/15.11.1865.

    Article  CAS  PubMed  Google Scholar 

  22. •• Friedman GS, Meier-Kriesche H, Kaplan B. Hypercoagulable states in renal transplant candidates: impact of anticoagulation upon incidence of renal allograft thrombosis. Transplantation. 2001;72(6):1073–8. https://doi.org/10.1097/00007890-200109270-00016. A study of incidence of anticoagulation therapy on long-term allograft function.

    Article  CAS  PubMed  Google Scholar 

  23. Murphy GJ, Taha R, Windmill DC, Metcalfe M, Nicholson ML. Influence of aspirin on early allograft thrombosis and chronic allograft nephropathy following renal transplantation. Br J Surg. 2001;88(2):261–6. https://doi.org/10.1046/j.1365-2168.2001.01671.x.

    Article  CAS  PubMed  Google Scholar 

  24. Morrissey PE, Ramirez PJ, Gohh RY, Yango AY, Kestin A, Madras PN, et al. Management of thrombophilia in renal transplant patients. Am J Transplant. 2002;2(9):872–6. https://doi.org/10.1034/j.1600-6143.2002.20910.x.

    Article  PubMed  Google Scholar 

  25. Osman Y, Kamal M, Soliman S, Sheashaa H, Shokeir A, Shehab el-Dein AB. Necessity of routine postoperative heparinization in non-risky live-donor renal transplantation: results of a prospective randomized trial. Urology. 2007;69(4):647–51. https://doi.org/10.1016/j.urology.2006.12.017.

    Article  PubMed  Google Scholar 

  26. Stechman MJ, Charlwood N, Gray D, Handa A. Administration of 75 mg of aspirin daily for 28 days is sufficient prophylaxis against renal transplant vein thrombosis. Phlebology. 2007;22(2):83–5. https://doi.org/10.1258/026835507780346187.

    Article  CAS  PubMed  Google Scholar 

  27. Murashima M, Konkle BA, Bloom RD, Sood SL, Grossman RA, Brunelli SM, et al. A single-center experience of preemptive anticoagulation for patients with risk factors for allograft thrombosis in renal transplantation. Clin Nephrol. 2010;74(11):351–7. https://doi.org/10.5414/CNP74351.

    Article  CAS  PubMed  Google Scholar 

  28. Canaud G, Bienaime F, Noel LH, Royal V, Alyanakian MA, Dautzenberg MD, et al. Severe vascular lesions and poor functional outcome in kidney transplant recipients with lupus anticoagulant antibodies. Am J Transplant. 2010;10(9):2051–60. https://doi.org/10.1111/j.1600-6143.2010.03233.x.

    Article  CAS  PubMed  Google Scholar 

  29. Ghisdal L, Broeders N, Wissing KM, Saidi A, Bensalem T, Mbaba Mena J, et al. Thrombophilic factors do not predict outcomes in renal transplant recipients under prophylactic acetylsalicylic acid. Am J Transplant. 2010;10(1):99–105. https://doi.org/10.1111/j.1600-6143.2009.02855.x.

    Article  CAS  PubMed  Google Scholar 

  30. Moscarelli L, Zanazzi M, Bertoni E, Caroti L, Rosso G, Farsetti S, et al. Renin angiotensin system blockade and activated vitamin D as a means of preventing deep vein thrombosis in renal transplant recipients. Clin Nephrol. 2011;75(05):440–50. https://doi.org/10.5414/CNP75440.

    Article  CAS  PubMed  Google Scholar 

  31. Pawlicki J, Cierpka L, Krol R, Ziaja J. Risk factors for early hemorrhagic and thrombotic complications after kidney transplantation. Transplant Proc. 2011;43(8):3013–7. https://doi.org/10.1016/j.transproceed.2011.07.018.

    Article  CAS  PubMed  Google Scholar 

  32. Eng M, Brock G, Li X, Chen Y, Ravindra KV, Buell JF, et al. Perioperative anticoagulation and antiplatelet therapy in renal transplant: is there an increase in bleeding complication? Clin Transpl. 2011;25(2):292–6. https://doi.org/10.1111/j.1399-0012.2010.01293.x.

    Article  Google Scholar 

  33. Bakkaloglu H, Salmaslioglu A, Tunca F, Serin KR, Agcaoglu O, Nane I, et al. Is heparinization necessary in the early postoperative period of renal transplantation from cadaveric donors? Transplant Proc. 2012;44(6):1690–3. https://doi.org/10.1016/j.transproceed.2012.05.048.

    Article  CAS  PubMed  Google Scholar 

  34. Sakalli H, Baskin E, Bayrakçi US, Gülleroglu KS, Moray G, Haberal M. Mean platelet volume as a potential predictor of renovascular thrombosis after renal transplant. Exp Clin Transplant. 2012;11(1):27–31. https://doi.org/10.6002/ect.2012.0128.

    Article  Google Scholar 

  35. Hwang JK, Kim JM, Lim JH, Chung BH, Choi BS, Yang CW, et al. Incidence of deep vein thrombosis in the first month after kidney transplantation in Korean versus Caucasian populations. Thromb Res. 2013;131(3):e120–2. https://doi.org/10.1016/j.thromres.2013.01.004.

    Article  CAS  PubMed  Google Scholar 

  36. Todeschini P, La Manna G, Dalmastri V, Feliciangeli G, Cuna V, Montanari M, et al. Incidence of late deep venous thrombosis among renal transplant patients. Transplant Proc. 2013;45(7):2666–8. https://doi.org/10.1016/j.transproceed.2013.07.017.

    Article  CAS  PubMed  Google Scholar 

  37. Jun KW, Park KM, Kim MH, Hwang JK, Park SC, Moon IS, et al. Mechanical thromboprophylaxis is sufficient to prevent the lower extremity deep vein thrombosis after kidney transplantation. Ann Surg Treat Res. 2014;87(1):28–34. https://doi.org/10.4174/astr.2014.87.1.28.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Musetti C, Quaglia M, Cena T, Battista M, Fenoglio R, Lazzarich E, et al. Impact of pre-transplant antiaggregant and anticoagulant therapies on early hemorrhagic and cardiovascular events after kidney transplantation. J Nephrol. 2015;28(6):757–64. https://doi.org/10.1007/s40620-015-0185-1.

    Article  CAS  PubMed  Google Scholar 

  39. •• Verhave JC, Tagalakis V, Suissa S, Madore F, Hebert MJ, Cardinal H. The risk of thromboembolic events in kidney transplant patients. Kidney Int. 2014;85(6):1454–60. https://doi.org/10.1038/ki.2013.536. Study with large cohort and long follow-up.

    Article  CAS  PubMed  Google Scholar 

  40. Abualhassan N, Aljiffry M, Thalib L, Coussa R, Metrakos P, Hassanain M. Post-transplant venous thromboembolic events and their effect on graft survival. Saudi J Kidney Dis Transpl. 2015;26(1):1–5.

    Article  PubMed  Google Scholar 

  41. Jonsson A, Kayler LK. Kidney transplantation without interruption of warfarin. Clin Transpl. 2015;29(8):665–6. https://doi.org/10.1111/ctr.12573.

    Article  Google Scholar 

  42. Musetti C, Battista M, Izzo C, Stratta P. Kidney transplant recipients receiving mTOR inhibitors experienced twice as many thrombotic events: a single cohort observational study. Thromb Res. 2014;134(4):928–30. https://doi.org/10.1016/j.thromres.2014.08.001.

    Article  CAS  PubMed  Google Scholar 

  43. Yagmur E, Frank RD, Neulen J, Floege J, Muhlfeld AS. Platelet hyperaggregability is highly prevalent in patients with chronic kidney disease: an underestimated risk indicator of thromboembolic events. Clin Appl Thromb Hemost. 2015;21(2):132–8. https://doi.org/10.1177/1076029613490828.

    Article  PubMed  Google Scholar 

  44. Ng JC, Leung M, Landsberg D. Evaluation of heparin anticoagulation protocols in post-renal transplant recipients (EHAP-PoRT study). Can J Hosp Pharm. 2016;69(2):114–21.

    PubMed  PubMed Central  Google Scholar 

  45. Musso D, Robaina GI, Figueroa Cordoba AV, Martini GD, Albertini RA, Chiurchiu C, et al. Symptomatic venous thromboembolism and major bleeding after renal transplantation: should we use pharmacologic thromboprophylaxis? Transplant Proc. 2016;48(8):2773–8. https://doi.org/10.1016/j.transproceed.2016.07.022.

    Article  CAS  PubMed  Google Scholar 

  46. Soo Hoo GW. Overview and assessment of risk factors for pulmonary embolism. Expert Rev Respir Med. 2013;7(2):171–91. https://doi.org/10.1586/ers.13.7.

    Article  PubMed  Google Scholar 

  47. •• Parajuli S, Lockridge JB, Langewisch ED, Norman DJ, Kujovich JL. Hypercoagulability in kidney transplant recipients. Transplantation. 2016;100(4):719–26. https://doi.org/10.1097/TP.0000000000000887. Comprehensive review of hypercoagulability mechanisms.

    Article  CAS  PubMed  Google Scholar 

  48. Andrassy J, Zeier M, Andrassy K. Do we need screening for thrombophilia prior to kidney transplantation? Nephrol Dial Transplant. 2004;19(Suppl 4):iv64–8.

    PubMed  Google Scholar 

  49. •• Ponticelli C, Moia M, Montagnino G. Renal allograft thrombosis. Nephrol Dial Transplant. 2009;24(5):1388–93. https://doi.org/10.1093/ndt/gfp003. Comprehensive review of graft thrombosis with proposed algorithm for prophylaxis.

    Article  PubMed  Google Scholar 

  50. Keller AK, Jorgensen TM, Jespersen B. Identification of risk factors for vascular thrombosis may reduce early renal graft loss: a review of recent literature. J Transp Secur. 2012;2012:793461.

    Google Scholar 

  51. Goldhaber SZ, Bounameaux H. Pulmonary embolism and deep vein thrombosis. Lancet. 2012;379(9828):1835–46. https://doi.org/10.1016/S0140-6736(11)61904-1.

    Article  PubMed  Google Scholar 

  52. Geerts WH, Bergqvist D, Pineo GF, Heit JA, Samama CM, Lassen MR, et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition). Chest. 2008;133(6):381S–453S. https://doi.org/10.1378/chest.08-0656.

    Article  CAS  PubMed  Google Scholar 

  53. Yang Y, Lv J, Zhou F, Chen M, Wang R, Zhao M, et al. Risk factors of pulmonary thrombosis/embolism in nephrotic syndrome. Am J Med Sci. 2014;348(5):394–8. https://doi.org/10.1097/MAJ.0000000000000315.

    Article  PubMed  Google Scholar 

  54. Kazory A, Ducloux D. Acquired hypercoagulable state in renal transplant recipients. Thromb Haemost. 2004;91(4):646–54. https://doi.org/10.1160/TH03-09-0568.

    CAS  PubMed  Google Scholar 

  55. Sforza D, Iaria G, Tariciotti L, Manuelli M, Anselmo A, Ciano P, et al. Deep vein thrombosis as debut of cytomegalovirus infection associated with type II cryoglobulinemia, with antierythrocyte specificity in a kidney transplant recipient: a case report. Transplant Proc. 2013;45(7):2782–4. https://doi.org/10.1016/j.transproceed.2013.07.004.

    Article  CAS  PubMed  Google Scholar 

  56. Baas MC, Gerdes VE, Ten Berge IJ, Heutinck KM, Florquin S, Meijers JC, et al. Treatment with everolimus is associated with a procoagulant state. Thromb Res. 2013;132(2):307–11. https://doi.org/10.1016/j.thromres.2013.07.004.

    Article  CAS  PubMed  Google Scholar 

  57. Gigante A, Di Mario F, Pierucci A, Amoroso A, Pignataro FS, Napoleone L, et al. Kidney disease and venous thromboembolism: does being woman make the difference? Eur J Intern Med. 2017;39:18–23. https://doi.org/10.1016/j.ejim.2017.02.012.

    Article  CAS  PubMed  Google Scholar 

  58. Chunduri S, Folstad JE, Vachharajani TJ. Antithrombotic therapy in end-stage renal disease. Hemodial Int. 2017;21(4):453–71. https://doi.org/10.1111/hdi.12571.

    Article  PubMed  Google Scholar 

  59. Hale G, Brenner M. Risks and benefits of low molecular-weight heparin and target-specific oral anticoagulant use for thromboprophylaxis in medically ill patients. Am J Cardiovasc Drugs. 2015;15(5):311–22. https://doi.org/10.1007/s40256-015-0122-7.

    Article  CAS  PubMed  Google Scholar 

  60. Vlachopanos G, Ghalli FG. Antithrombotic medications in dialysis patients: a double-edged sword. J Evid Based Med. 2017;10(1):53–60. https://doi.org/10.1111/jebm.12235.

    Article  PubMed  Google Scholar 

  61. Di Lullo L, Ronco C, Cozzolino M, Russo D, Russo L, Di Iorio B, et al. Nonvitamin K-dependent oral anticoagulants (NOACs) in chronic kidney disease patients with atrial fibrillation. Thromb Res. 2017;155:38–47. https://doi.org/10.1016/j.thromres.2017.04.027.

    Article  PubMed  Google Scholar 

  62. Lutz J, Jurk K, Schinzel H. Direct oral anticoagulants in patients with chronic kidney disease: patient selection and special considerations. Int J Nephrol Renovasc Dis. 2017;10:135–43. https://doi.org/10.2147/IJNRD.S105771.

    Article  PubMed  PubMed Central  Google Scholar 

  63. • Salerno DM, Tsapepas D, Papachristos A, Chang JH, Martin S, Hardy MA, et al. Direct oral anticoagulant considerations in solid organ transplantation: a review. Clin Transpl. 2017;31:1–13. Updated information on anticoagulant agents on solid organ transplant recipients.

    Article  Google Scholar 

  64. Belmar Vega L, de Francisco ALM, Bada da Silva J, Galvan Espinoza L, Fernandez Fresnedo G. New oral anticoagulants in patients with chronic kidney disease. Nefrologia. 2017;37(3):244–52. https://doi.org/10.1016/j.nefro.2016.08.006.

    Article  PubMed  Google Scholar 

  65. • Willett KC, Morrill AM. Use of direct oral anticoagulants for the prevention and treatment of thromboembolic disease in patients with reduced renal function: a short review of the clinical evidence. Ther Clin Risk Manag. 2017;13:447–54. https://doi.org/10.2147/TCRM.S88911. Updated recommended dosing for direct oral anticoagulants in subpopulation, discussion of adherence and costs.

    Article  PubMed  PubMed Central  Google Scholar 

  66. Turpie AGG, Purdham D, Ciaccia A. Nonvitamin K antagonist oral anticoagulant use in patients with renal impairment. Ther Adv Cardiovasc Dis. 2017;11(9):243–56. https://doi.org/10.1177/1753944717714921.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  67. Sanchez Fuentes D, Budino Sanchez MA, Lopez Sanchez MP. Use of oral anticoagulation for patients who undergo invasive procedures. Rev Clin Esp. 2017;217(2):103–7. https://doi.org/10.1016/j.rceng.2016.06.007.

    Article  CAS  PubMed  Google Scholar 

  68. Esfandiar N, Otukesh H, Sharifian M, Hoseini R. Protective effect of heparin and aspirin against vascular thrombosis in pediatric kidney transplants. Iran J Kidney Dis. 2012;6(2):141–5.

    PubMed  Google Scholar 

  69. Haberal M, Boyvat F, Akdur A, Kirnap M, Ozcelik U, Yarbug Karakayali F. Surgical complications after kidney transplantation. Exp Clin Transplant. 2016;14(6):587–95.

    PubMed  Google Scholar 

  70. Palmer SC, Di Micco L, Razavian M, Craig JC, Perkovic V, Pellegrini F, et al. Antiplatelet agents for chronic kidney disease. Cochrane Database Syst Rev. 2013;2013:CD008834.

    Google Scholar 

  71. • Tikkinen KAO, Craigie S, Agarwal A, Siemieniuk RAC, Cartwright R, Violette PD, et al. Procedure-specific risks of thrombosis and bleeding in urological non-cancer surgery: systematic review and meta-analysis. Eur Urol. 2017;16(3):e1033–4. https://doi.org/10.1016/S1569-9056(17)30653-X. An updated and comprehensive summary of the evidence regarding risks of bleeding and thrombotic events in surgery.

    Article  Google Scholar 

  72. Gouin B, Robert-Ebadi H, Righini M, Blondon M. Pharmacological management of pulmonary embolism. Expert Opin Pharmacother. 2017;18(1):79–93. https://doi.org/10.1080/14656566.2016.1268122.

    Article  CAS  PubMed  Google Scholar 

  73. Saheb Sharif-Askari F, Syed Sulaiman SA, Saheb Sharif-Askari N. Anticoagulation therapy in patients with chronic kidney disease. Adv Exp Med Biol. 2017;906:101–14. https://doi.org/10.1007/5584_2016_109.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Foundation for Research and Assistance in Kidney Disease—FINAER, Austria 2381, 5D, 1425, Buenos Aires, Argentina

    Federico Cicora, Jorgelina Petroni & Javier Roberti

Authors
  1. Federico Cicora
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jorgelina Petroni
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Javier Roberti
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Javier Roberti.

Ethics declarations

Conflict of Interest

Federico Cicora, Jorgelina Petroni, and Javier Roberti declare that they have no potential conflicts of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Kidney Diseases

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cicora, F., Petroni, J. & Roberti, J. Prophylaxis of Pulmonary Embolism in Kidney Transplant Recipients. Curr Urol Rep 19, 17 (2018). https://doi.org/10.1007/s11934-018-0759-2

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11934-018-0759-2

Keywords

Search

Navigation